TWM451970U - Antrodia camphorata capsule structure - Google Patents
Antrodia camphorata capsule structure Download PDFInfo
- Publication number
- TWM451970U TWM451970U TW101221144U TW101221144U TWM451970U TW M451970 U TWM451970 U TW M451970U TW 101221144 U TW101221144 U TW 101221144U TW 101221144 U TW101221144 U TW 101221144U TW M451970 U TWM451970 U TW M451970U
- Authority
- TW
- Taiwan
- Prior art keywords
- capsule
- peripheral wall
- convex
- ring
- ring portion
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本創作是關於一種膠囊構造,特別是一種可增加膠囊接合穩固性的牛樟芝膠囊構造創作。The present invention relates to a capsule construction, in particular to a construction of an Antrodia camphorata capsule which can increase the stability of capsule bonding.
牛樟芝(Antrodia camphorata)之生理活性物質以三萜類(Triterpenoids)等化合物為主。由於牛樟芝經科學研究富含許多有益人體的活性成分,被視為有助於肝臟保健與強身功能之食品。因此,基於保健的理由,許多人選擇服用主要含有樟芝萃取物的保健食品。The physiologically active substance of Antrodia camphorata is mainly composed of compounds such as Triterpenoids. Because of its scientific research, Borneoside is rich in many active ingredients that are beneficial to the body and is considered to be a food that helps liver health and body function. Therefore, for health reasons, many people choose to take health foods that mainly contain Antrodia camphorata extract.
目前市面上以牛樟芝萃取物作為主成分的保健食品中,概以錠劑或膠囊型式為主,由於牛樟芝萃取物之三萜類成分具有特殊辛、苦味,人們服用牛樟芝錠劑時,易因味苦而不太為人們所接受,故市面上以牛樟芝膠囊產品居多。At present, the health foods containing the extract of Antrodia camphorata as the main component are mainly in the form of tablets or capsules. Because the triterpenoids of the extract of Antrodia camphorata have special pungent and bitter taste, when people take the extract of Antrodia camphorata, it is easy to taste. Bitter and not very acceptable to people, so the market is mostly Niuzhizhi capsule products.
惟現有牛樟芝膠囊主要係於一膠囊體中裝填粉末狀牛樟芝複方物,該膠囊體係由二膠囊對接組合而成,由於該膠囊為光滑表面的套合構造,造成二膠囊接合後存在結合穩合性不佳之缺點,而易發生膠囊鬆脫以致膠囊體內部之牛樟芝粉末易散出之問題。However, the existing Antrodia sinensis capsules are mainly filled with powdered Antrodia camphorata compound in a capsule body. The capsule system is made up of two capsules butt joints. Because the capsule has a smooth surface nesting structure, there is a binding stability after the two capsules are joined. The disadvantages of poorness are prone to the problem that the capsule is loosened and the burdock powder inside the capsule body is easily dispersed.
本創作之主要目的在於提供一種牛樟芝膠囊構造,希藉此創作解決現有牛樟芝膠囊構造中,膠囊體之二膠囊接合穩固性不佳之問題。The main purpose of this creation is to provide a capsule structure of Niuzhizhi, and to create a solution to the problem of poor stability of the capsules of the capsules in the construction of the existing Antrodia camphorata capsules.
為達成前揭目的,本創作所提出之牛樟芝膠囊構造係包含一中空的膠囊體與裝填於膠囊體內部的牛樟芝複方物,該膠囊體係由第一膠囊與第二膠囊對接而成,第一膠囊與第二膠囊皆係一圓管形基部一端形成一半圓球形的封閉端,且於圓管形基部另一端形成一圓形開口端,第二膠囊外部直徑對應於第一膠囊的內部直徑,第二膠囊能以其開口端經由第一膠囊的開口端之開口置入其中而接合一起;第一膠囊於鄰近半圓球形封閉端處之周壁形成一外凹內凸的第一固接環部,第一固接環部於周壁外周面形成內凹的第一環凹部,於周壁內周面形成凸出的第一環凸部,第二膠囊於鄰近開口端之周壁形成一外凹內凸的第二固接環部,第二固接環部於第二膠囊之周壁外周面形成內凹的第二環凹部,於第二膠囊之周壁內周面形成凸出的第二環凸部,第二膠囊以其開口端置入第一膠囊的開口端之開口內,使第一膠囊之第一固接環部內周緣的凸狀第一環凸部卡合於第二膠囊之第二固接環部外周緣的凹狀第二環凹部。In order to achieve the premise, the Niuzhizhi capsule structure proposed by the present invention comprises a hollow capsule body and an anatase compound filled in the capsule body, the capsule system is formed by the first capsule and the second capsule being docked, the first capsule Forming a semi-spherical closed end at one end of the tubular body with the second capsule, and forming a circular open end at the other end of the circular tubular base, the outer diameter of the second capsule corresponding to the inner diameter of the first capsule, and the second The capsule can be joined together with its open end inserted through the opening of the open end of the first capsule; the first capsule forms a first concavely convex first fixed ring portion at a peripheral wall adjacent to the semicircular closed end, first The fixing ring portion forms a concave first ring concave portion on the outer circumferential surface of the peripheral wall, and a convex first ring convex portion is formed on the inner circumferential surface of the peripheral wall, and the second capsule forms a second concave convex second portion on the peripheral wall adjacent to the open end Fixing the ring portion, the second fixing ring portion forms a concave second ring concave portion on the outer circumferential surface of the peripheral wall of the second capsule, and forms a convex second ring convex portion on the inner circumferential surface of the second capsule, the second capsule Open end Inserting into the opening of the open end of the first capsule, the convex first ring convex portion of the inner circumference of the first fixed ring portion of the first capsule is engaged with the concave shape of the outer periphery of the second fixed ring portion of the second capsule Second ring recess.
藉由前揭牛樟芝膠囊構造之創作,其主要利用膠囊體之第一膠囊與第二膠囊間利用相對應的第一固接環部與第二固接環部凹凸配合之卡接組合構造,使第一膠囊與第二膠囊接合後得以呈現穩固組合狀態,克服現有牛樟芝膠囊構造中,膠囊體之第一膠囊與第二膠囊接合穩固性不佳之問題。By the creation of the structure of the burdock capsule, the first capsule and the second capsule are respectively configured by using a corresponding snap-fit combination of the first fixing ring portion and the second fixing ring portion. The first capsule and the second capsule are combined to exhibit a stable combined state, which overcomes the problem that the first capsule and the second capsule of the capsule body are not stably anchored in the existing O. chinensis capsule construction.
本創作之次一目的,係令第一固接環部厚度與第一膠囊之圓管形基部周壁厚度實質相等,第二固接環部厚度與 第二膠囊之圓管形基部周壁厚度實質相等。使其可藉由加壓成形手段令第一膠囊與第二膠囊上直接形成第一、第二固接環部,無須作厚度上的變更,以利製造。The second purpose of the present invention is that the thickness of the first fixing ring portion is substantially equal to the thickness of the peripheral wall of the circular tubular base of the first capsule, and the thickness of the second fixing ring portion is The thickness of the peripheral wall of the tubular base of the second capsule is substantially equal. The first and second fixing ring portions can be directly formed on the first capsule and the second capsule by press forming means, and the thickness is not changed, so as to facilitate manufacturing.
如圖1所示,係揭示本創作牛樟芝膠囊構造之一較佳實施例,該牛樟芝膠囊構造係包含一中空的膠囊體1與裝填於膠囊體1內部的牛樟芝複方物2,其中:所述膠囊體1係由第一膠囊10與第二膠囊20對接而成,所述第一膠囊10與第二膠囊20皆係一圓管形基部11、21一端形成一半圓球形的封閉端12、22,於圓管形基部11、21另一端形成一圓形開口端13、23,且第二膠囊20外部直徑對應於第一膠囊10的內部直徑,如圖2所示,使第二膠囊20能以其開口端經由第一膠囊10的開口端13之開口置入其中而接合一起,其中,如圖1及圖3所示,第一膠囊10於其圓管形基部11鄰近半圓球形封閉端12處之周壁形成一外凹內凸的第一固接環部14,所述第一固接環部14於周壁外周面形成內凹的第一環凹部141,於周壁內周面形成凸出周壁表面的第一環凸部142,第二膠囊20於鄰近開口端之周壁形成一外凹內凸的第二固接環部24,並使所述第二固接環部24於第二膠囊20之圓管形基部21的周壁外周面形成內凹的第二環凹部241,於第二膠囊20之圓管形基部21的周壁內周面形成凸出周壁表面的第二環凸部242,使第二膠囊20以其開口端23經由第一膠囊10的開口端13之開口置入後,利用第一膠囊10之第一固接環部14內周緣的凸狀第一環凸部142卡合於第二膠囊20之第二固接環部 24外周緣的凹狀第二環凹部241而接合固定。As shown in FIG. 1, a preferred embodiment of the present invention relates to a structure of a burdock capsule comprising a hollow capsule body 1 and an anatase compound 2 loaded inside the capsule body 1, wherein: the capsule The body 1 is formed by abutting the first capsule 10 and the second capsule 20, and the first capsule 10 and the second capsule 20 are each formed by a rounded base portion 11, 21 forming a semi-spherical closed end 12, 22 The other ends of the circular tubular bases 11, 21 form a circular open end 13, 23, and the outer diameter of the second capsule 20 corresponds to the inner diameter of the first capsule 10, as shown in Fig. 2, enabling the second capsule 20 to The open end is joined together via an opening of the open end 13 of the first capsule 10, wherein, as shown in Figures 1 and 3, the first capsule 10 is adjacent to the semicircular closed end 12 at its cylindrical base 11 The peripheral wall defines a first concave ring portion 14 which is convex and convex, and the first fixing ring portion 14 forms a concave first ring concave portion 141 on the outer circumferential surface of the peripheral wall, and forms a convex peripheral wall surface on the inner circumferential surface of the peripheral wall. The first ring protrusion 142, the second capsule 20 forms an outer wall adjacent to the peripheral wall of the open end The second second fixing ring portion 24 is formed, and the second fixing ring portion 24 forms a concave second ring concave portion 241 on the outer circumferential surface of the peripheral wall of the tubular base portion 21 of the second capsule 20, and The inner circumferential surface of the peripheral wall of the circular tubular base portion 21 of the capsule 20 forms a second annular convex portion 242 projecting from the peripheral wall surface, so that the second capsule 20 is placed with its open end 23 through the opening of the open end 13 of the first capsule 10. The convex first ring protrusion 142 of the inner circumference of the first fixing ring portion 14 of the first capsule 10 is engaged with the second fixing ring portion of the second capsule 20 The concave second ring recess 241 of the outer periphery of the outer periphery is joined and fixed.
前述中,如圖3所示,所述第一固接環部14與第二固接環部24係分別利用加壓成形手段施加於第一膠囊10、第二膠囊20之周壁而成外凹內凸之環狀,使第一固接環部14厚度與第一膠囊10之圓管形基部11周壁厚度實質相等,第二固接環部24厚度與第二膠囊20之圓管形基部21周壁厚度實質相等。As described above, as shown in FIG. 3, the first fixing ring portion 14 and the second fixing ring portion 24 are respectively applied to the peripheral walls of the first capsule 10 and the second capsule 20 by a press forming means. The inner convex ring has a thickness such that the thickness of the first fixing ring portion 14 is substantially equal to the thickness of the peripheral wall of the tubular base portion 11 of the first capsule 10, and the thickness of the second fixing ring portion 24 and the tubular base portion 21 of the second capsule 20. The thickness of the peripheral wall is substantially equal.
所述牛樟芝複方物2包含有三萜類化合物、免疫蛋白、麥角固醇、核酸及血壓穩固物等組成分的粉末或小顆粒物。其中三萜類化合物主要功有抑制癌細胞成長、抑制癌組織胺的釋放、防止過敏、降低血壓及抗發炎...等作用,再搭配免疫蛋白、麥角固醇、核酸及血壓穩固物等組成分,使該牛樟芝複方物具備有助於人體保健之功效。The Antrodia camphorata complex 2 contains a powder or small particles of a composition such as a triterpenoid compound, an immunoprotein, ergosterol, a nucleic acid, and a blood pressure stabilizer. Among them, triterpenoids mainly inhibit the growth of cancer cells, inhibit the release of cancer histamine, prevent allergies, lower blood pressure and anti-inflammatory, etc., together with immune proteins, ergosterol, nucleic acids and blood pressure stabilizers. The composition of the group makes the Astragalus membranaceus compound have the effect of contributing to human health care.
本創作牛樟芝膠囊構造之創作,並利用膠囊體1之第一膠囊10與第二膠囊20間相對應的第一固接環部14與第二固接環部24凹凸配合之卡接組合構造,使第一膠囊10與第二膠囊20接合後得以呈現穩固組合狀態,使裝填於膠囊體1內部的牛樟芝複方物2不易因膠囊體鬆脫而散出。The creation of the structure of the burdock capsule, and the combination of the first fixing ring portion 14 and the second fixing ring portion 24 corresponding to each other between the first capsule 10 and the second capsule 20 of the capsule body 1 is combined with each other. When the first capsule 10 and the second capsule 20 are joined, a stable combination state is exhibited, so that the Antrodia camphora compound 2 loaded inside the capsule body 1 is less likely to be released by the capsule body being loosened.
1‧‧‧膠囊體1‧‧‧ capsule body
2‧‧‧牛樟芝複方物2‧‧‧ Antrodia complex
10‧‧‧第一膠囊10‧‧‧ first capsule
11‧‧‧圓管形基部11‧‧‧round tube base
12‧‧‧封閉端12‧‧‧closed end
13‧‧‧開口端13‧‧‧Open end
14‧‧‧第一固接環部14‧‧‧First fixed ring
141‧‧‧第一環凹部141‧‧‧First ring recess
142‧‧‧第一環凸部142‧‧‧First ring convex
20‧‧‧第二膠囊20‧‧‧Second capsule
21‧‧‧圓管形基部21‧‧‧round tube base
22‧‧‧封閉端22‧‧‧closed end
23‧‧‧開口端23‧‧‧Open end
24‧‧‧第二固接環部24‧‧‧Second fixed ring
241‧‧‧第二環凹部241‧‧‧ Second ring recess
242‧‧‧第二環凸部242‧‧‧second ring convex
圖1係本創作牛樟芝膠囊構造之一較佳實施例的立體分解示意圖。Fig. 1 is a perspective exploded view showing a preferred embodiment of the present invention.
圖2係圖1所示牛樟芝膠囊構造較佳實施例組合後的立體示意圖。Fig. 2 is a perspective view showing the combination of the preferred embodiment of the structure of the burdock capsule shown in Fig. 1.
圖3係圖1所示牛樟芝膠囊構造較佳實施例組合後的剖面示意圖。Figure 3 is a schematic cross-sectional view showing a preferred embodiment of the construction of the Antrodia camphorata capsule shown in Figure 1.
1‧‧‧膠囊體1‧‧‧ capsule body
2‧‧‧牛樟芝複方物2‧‧‧ Antrodia complex
10‧‧‧第一膠囊10‧‧‧ first capsule
12‧‧‧封閉端12‧‧‧closed end
14‧‧‧第一固接環部14‧‧‧First fixed ring
141‧‧‧第一環凹部141‧‧‧First ring recess
142‧‧‧第一環凸部142‧‧‧First ring convex
20‧‧‧第二膠囊20‧‧‧Second capsule
22‧‧‧封閉端22‧‧‧closed end
24‧‧‧第二固接環部24‧‧‧Second fixed ring
241‧‧‧第二環凹部241‧‧‧ Second ring recess
242‧‧‧第二環凸部242‧‧‧second ring convex
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW101221144U TWM451970U (en) | 2012-11-01 | 2012-11-01 | Antrodia camphorata capsule structure |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW101221144U TWM451970U (en) | 2012-11-01 | 2012-11-01 | Antrodia camphorata capsule structure |
Publications (1)
Publication Number | Publication Date |
---|---|
TWM451970U true TWM451970U (en) | 2013-05-01 |
Family
ID=49078433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW101221144U TWM451970U (en) | 2012-11-01 | 2012-11-01 | Antrodia camphorata capsule structure |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWM451970U (en) |
-
2012
- 2012-11-01 TW TW101221144U patent/TWM451970U/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2436558C2 (en) | Pharmaceutical product | |
CN104379006B (en) | It is accommodated with the capsule of liquid and possesses the smoking article of the capsule | |
IL205488A (en) | Pharmaceutical or nutraceutical preparations comprising a core containing an active substance, an inner layer surrounding the core and an outer layer, a tablet, a gelatin or hpmc capsule comprising them and preparation thereof | |
JP2013505928A5 (en) | ||
AU2014246703B2 (en) | Capsule with internal diaphragm | |
JP6082850B2 (en) | Multi-compartment formulation | |
JP2006342148A5 (en) | ||
TWM451970U (en) | Antrodia camphorata capsule structure | |
USD636071S1 (en) | Capsule for pharmaceutical products | |
CN205215740U (en) | Hollow capsule of leak protection powder | |
CN204352220U (en) | A kind of capsule being provided with reinforcement button | |
CN209500315U (en) | Ganoderma lucidum mycelium capsule structure | |
JP2012530691A5 (en) | ||
JPS63135174A (en) | Freely dividable capsule | |
US9101546B2 (en) | Capsule for encapsulating a tablet | |
CN206548831U (en) | A kind of Novel capsule | |
CN206867447U (en) | A kind of Capsules | |
CN206587194U (en) | A kind of multi-layer sealed capsule | |
CN208464683U (en) | A kind of glue class solid preparation of traditional Chinese medicine | |
WO2017136903A3 (en) | Capsule for two incompatible drugs | |
TWM479759U (en) | Capsule structure of Antrodia cinnamomea | |
CN104490068A (en) | Adhesive-free type lipstick packaging pipe | |
CN204444655U (en) | A kind of cosmetic active keeps Packaging Bottle | |
TWM328439U (en) | Model of beverage container | |
CN203425264U (en) | Divisible tablet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4K | Expiration of patent term of a granted utility model |